Patent · US Expired

Compounds

US6911458B2 · kind B2 · utility

4Cited by

15References

16Claims

0Family size

Assignee

AstraZeneca

Inventors

Tomas Eriksson · Kvicksund, SE
Tomas Klingstedt · Lund, SE
Tesfaledet Mussie · Lund, SE

Key dates

Filing date	Jun 14, 2001
Grant date	Jun 28, 2005
Priority date	—
Expiry date	Aug 4, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.